Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a related topic and a link to the Genetic and Rare Diseases Information Center in the page's Resources section.
    Difference
    0.1%
    Check dated 2026-04-02T01:32:49.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T17:42:54.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no changes to study content or results are visible.
    Difference
    0.0%
    Check dated 2026-03-11T16:46:49.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the funding lapse notice and prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:33:01.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A government funding status banner was added and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:15:21.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The page received minor UI and metadata updates, including showing the glossary, adding a QC status label, updating to revision v3.4.0, and capitalization adjustments to No FEAR Act text.
    Difference
    0.2%
    Check dated 2026-01-28T02:42:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.